+91 9650760803 
Published: March 8, 2021 | Updated: July 17, 2026
Key Takeaways
- 01. Treatment approach uses mesenchymal and umbilical-cord stem cells:
The clinic offers adult stem cells derived from human umbilical cord tissue and bone marrow for type 1 diabetes treatment in India. - 02. Goal is to regenerate beta-cell function and modulate immune response:
The therapy aims to replace or repair damaged pancreatic beta cells and reduce autoimmune attack. - 03. Evidence base remains preliminary:
Peer-reviewed studies on type 1 diabetes stem-cell therapy remain limited. It is described as an emerging treatment, not yet a standard of care. - 04. Patients should maintain standard diabetes care alongside experimental therapy:
Continuation of insulin therapy, blood-glucose monitoring, diet, and lifestyle management is advised while exploring stem-cell options.
Type 1 diabetes is an autoimmune condition in which the body’s own immune system mistakenly attacks and destroys the insulin-producing beta cells located in the pancreas. Unlike Type 2 diabetes, which develops gradually and is closely tied to insulin resistance, Type 1 diabetes typically results in an absolute insulin deficiency — the pancreas simply stops producing enough of the hormone needed to move glucose out of the bloodstream and into the body’s cells.
Without insulin, glucose builds up in the blood while the body’s cells are starved of the energy they need. This drives many of the hallmark symptoms of the condition — excessive thirst, frequent urination, and unexplained weight loss — and, if untreated, can progress to a dangerous condition called diabetic ketoacidosis (DKA), in which the body burns fat for fuel and produces a build-up of acidic ketones in the blood.
Researchers have not identified a single cause of Type 1 diabetes, but genetics appear to play a meaningful role, and viral infections (including certain strains of coxsackievirus, rubella, mumps, and rotavirus) are believed to potentially act as environmental triggers in genetically susceptible individuals. Because Type 1 diabetes is an immune-driven disease rather than purely a metabolic one, it often coexists with other autoimmune conditions such as Graves’ disease or vitiligo.
Since Type 1 diabetes requires insulin for survival, patients traditionally manage the condition through lifelong insulin therapy, careful glucose monitoring, and lifestyle adjustment. This has led to significant interest in regenerative approaches such as stem cell therapy, which is being researched for its potential to support beta cell regeneration and help modulate the underlying autoimmune activity — a different mechanistic target than the insulin-resistance focus explored for Type 2 diabetes. Viezec works with a network of hospitals in Delhi offering investigational stem cell programs, alongside full patient support services for domestic and international patients exploring this option.
Causes
Type 1 diabetes develops when the immune system erroneously identifies insulin-producing pancreatic beta cells as a threat and destroys them. This process can unfold gradually — sometimes over months or even years — before insulin production drops low enough for symptoms to appear.
Genetics play a measurable role. Research indicates that a person with no family history of Type 1 diabetes has roughly a 0.4% chance of developing the condition. If the mother has Type 1 diabetes, a child’s risk rises to approximately 1–4%; if the father has it, the risk is closer to 3–8%. When both parents are affected, the risk can climb to around 30%.
Environmental triggers may also be involved. Many researchers believe that in individuals who are already genetically predisposed, an external trigger — such as a viral infection or an environmental toxin — may be what actually sets off the immune system’s attack on the pancreas. This combination of inherited susceptibility and an environmental “trigger” is the leading theory behind why Type 1 diabetes develops in some people and not others.
Because the underlying cause is autoimmune rather than lifestyle-driven, Type 1 diabetes cannot be prevented through diet or exercise — a key distinction from Type 2 diabetes, which is more closely linked to weight and metabolic factors. For a broader look at how both types compare, see our main Diabetes Stem Cell Treatment page.
Symptoms
Type 1 diabetes symptoms tend to appear relatively quickly — often over the course of weeks rather than months — and can be more severe at onset than those seen in Type 2 diabetes. Common signs include:
- Constant or unusual thirst
- Frequent urination, including at night
- Increased hunger, even shortly after eating
- Blurry vision
- Unexplained and often rapid weight loss
- Persistent fatigue and weakness
- Cuts, bruises, or sores that heal slowly
- More frequent infections than usual
- Nausea, vomiting, abdominal pain, or difficulty breathing — which can signal the onset of diabetic ketoacidosis and require urgent medical attention
Because symptoms can escalate quickly, especially in children and young adults, prompt evaluation is important. If you notice a combination of these signs, timely diagnostic testing can help confirm the diagnosis early, before complications such as ketoacidosis develop.
Diagnosis
If Type 1 diabetes is suspected, your physician will typically order a combination of the following tests:
- Blood Glucose Test — Measures the amount of sugar in the blood, often performed both fasting and non-fasting to confirm elevated levels.
- Antibody Test — Checks for autoantibodies, which are immune-system proteins that mistakenly target the body’s own tissue. The presence of specific autoantibodies is a strong indicator of Type 1 diabetes.
- Glycosylated Hemoglobin Test (A1C) — Measures average blood sugar levels over roughly the past three months, providing a longer-term picture beyond a single blood draw.
To evaluate overall health and rule out diabetic ketoacidosis, doctors may also order:
- Basic Metabolic Panel — A blood test measuring eight key substances to assess metabolic and chemical balance in the body.
- Urinalysis — Examines the urine for ketones, a byproduct released when the body breaks down fat instead of glucose for energy. High ketone levels can indicate a dangerous, acidic shift in the blood.
For patients being evaluated for stem cell therapy specifically, our medical team typically requests the following additional reports:
- Blood Sugar — Fasting and Post-Prandial (PP)
- HbA1c
- Complete Blood Count (CBC)
- GAD-65 (Glutamic Acid Decarboxylase-65) antibody test
- Islet Cell Antibody, Serum
- Thyroid Profile, Total, Serum
These results, together with a full clinical history, help our specialists determine eligibility and design an appropriate care plan. See the Procedure section for what happens after your reports are reviewed.
Procedure
Patients who choose Viezec Stem Cell Institute are guided through a structured, multi-day process supported by our clinical team from arrival to discharge:
Day 1
- Airport pickup and transfer to the hospital.
- Initial consultation with the treating doctor to review your case and address questions.
- Completion of hospital admission formalities.
- Baseline lab work and clinical assessment.
- Start of any supportive therapies recommended by your doctor.
Day 2
- Once lab results are reviewed, the stem cell therapy procedure itself begins.
- Supportive therapies continue, tailored to individual treatment needs.
Day 3
- The day begins with continued supportive therapies under clinical supervision.
- Additional physiotherapy sessions may be included.
- Our team assists with discharge formalities.
- Airport drop-off is arranged.
Documents to bring for admission: Passport, Driving License, or PAN Card (any valid photo ID), along with hard copies of all relevant test reports.
This streamlined, three-day framework is designed to minimize disruption for international patients while ensuring each step — from diagnosis through implantation — is handled under close medical supervision.
Treatment
Stem cell–based approaches have become one of the most actively researched alternative avenues for Type 1 diabetes care. At Viezec, our partner hospitals offer access to mesenchymal stem cells (MSCs) sourced from adipose (fat) tissue and human umbilical cord tissue, both of which are being studied for their regenerative and immune-modulating properties.
Research has explored whether these stem cell derivatives may help improve glucose-responsive insulin secretion in Type 1 diabetes patients. Following extraction, the cells are transported to a laboratory for controlled cultivation under expert supervision before being administered to the patient through one of several delivery routes (see Implantation).
Because Type 1 diabetes involves both beta cell loss and ongoing autoimmune activity, the treatment approach differs somewhat from that used for Type 2 diabetes, where insulin resistance and metabolic inflammation are the primary targets. To understand the biological reasoning behind this approach, visit the Mechanism section below.
Implantation
Stem cells for Type 1 diabetes treatment may be delivered through several possible routes, selected based on the patient’s clinical profile:
- Intravenous administration
- Liberation angioplasty
- Intrathecal (lumbar puncture)
- Intra-arterial
- Subcutaneous
- Surgical administration
- Intramuscular
The chosen method (or combination of methods) is determined by the treating physician after reviewing a patient’s overall health, disease progression, and treatment goals. For a more technical explanation of how each delivery route works, visit our page on Stem Cell Delivery Methods.
Mechanism
Stem cells possess a distinctive capacity to self-renew and, under the right conditions, support the repair or replacement of damaged and injured cells. For Type 1 diabetes, cells are typically sourced from adipose fat tissue or umbilical cord tissue, then cultivated in a laboratory environment before being administered to the patient under close clinical supervision.
The full procedure is generally completed within a few hours and is designed to be minimally invasive. The core goal of this therapy is to support the repair and recovery of damaged pancreatic tissue — with the aim that healthier, newer cells may gradually support function that was previously compromised by the autoimmune process described in the Causes section.
To explore the underlying biological principles in more depth, visit our page on the Physiological Mechanism of Stem Cell Therapy.
Frequently Asked Questions
What is stem cell treatment for Type 1 Diabetes?
Stem cell treatment involves using specialized cells to regenerate insulin-producing beta cells in the pancreas, helping improve blood sugar control in individuals with Type 1 Diabetes.
Who is eligible for stem cell therapy for Type 1 Diabetes?
Candidates typically include individuals diagnosed with Type 1 Diabetes, especially those struggling with unstable blood sugar levels or requiring high insulin doses, subject to evaluation by a specialist.
How is the therapy administered?
Stem cells are usually delivered intravenously or injected into the pancreas through minimally invasive procedures, under strict clinical supervision to ensure safety and efficacy.
Is stem cell therapy safe for all age groups?
When performed in certified clinics with experienced medical teams, stem cell therapy is generally safe. Minor side effects may include temporary fever, fatigue, or localized inflammation.
How long does it take to see results?
Results vary per individual. Some patients notice improved blood sugar control within weeks, while others may require several months for significant changes, depending on disease severity and response to therapy.
How many sessions are typically required?
The number of sessions depends on individual needs. Most patients undergo 1–3 sessions, followed by regular monitoring of blood sugar levels and periodic check-ups to assess progress.
Can stem cell therapy replace insulin therapy?
Stem cell therapy may reduce dependence on insulin but is generally considered a complementary treatment. Patients may still require insulin or other medications based on their condition.
How can I schedule a consultation for stem cell therapy?
You can schedule a consultation by contacting our clinic via phone, email, or the online appointment form. Our team will evaluate your condition and provide a personalized treatment plan.
For more questions, visit our FAQs page or request an evaluation with our expert team.
How Much Does Stem Cell Therapy Cost for Type 1 Diabetes?
The cost of stem cell therapy for Type 1 Diabetes varies depending on several factors such as the patient’s age, insulin dependency level, stage of beta-cell damage, number of stem cell infusions required, and the medical center’s expertise. Treatment costs differ globally due to variations in healthcare infrastructure, clinical standards, and research advancement. Below is a general cost comparison across popular medical destinations.
Cost Comparison: Select Countries
The table below provides approximate cost ranges for a complete stem cell therapy program for Type 1 Diabetes, including stem cell preparation, administration, hospitalization, and follow-up evaluations.
| Country | Average Cost (in USD) | Average Cost (in INR) |
|---|---|---|
| United States 🇺🇸 | $22,000 – $38,000 | ₹18,20,000 – ₹31,50,000 |
| United Kingdom 🇬🇧 | $16,000 – $27,000 | ₹13,20,000 – ₹22,30,000 |
| Germany 🇩🇪 | $19,000 – $30,000 | ₹15,70,000 – ₹24,80,000 |
| South Korea 🇰🇷 | $14,000 – $24,000 | ₹11,60,000 – ₹19,90,000 |
| Singapore 🇸🇬 | $13,000 – $23,000 | ₹10,70,000 – ₹19,00,000 |
While developed nations like the USA, UK, and Germany offer advanced medical research and facilities, the overall cost of care is considerably higher due to insurance, staffing, and infrastructure expenses. In contrast, India provides the same global-quality treatment at significantly lower costs, making it a preferred destination for international patients seeking affordable and effective stem cell therapy for diabetes.
The affordability in India is driven by lower operational and clinical costs, favorable exchange rates, and efficient healthcare systems — without compromising on treatment safety or outcomes. Reputed Indian hospitals follow international cell processing standards, advanced laboratory techniques, and employ doctors trained in regenerative medicine to ensure high success rates for diabetic patients.
Why Choose Viezec?
Viezec collaborates with accredited hospitals and regenerative medicine experts offering world-class stem cell therapy in India. Our team ensures ethical medical practices, transparent cost structures, and personalized treatment guidance to achieve optimal results for patients with Type 1 Diabetes.
Get a Personalized Cost Estimate
Every diabetes case is unique. Contact our specialists today to receive a personalized quotation and a detailed treatment roadmap tailored to your condition.
Improvements
There is currently no established cure for Type 1 diabetes. Interestingly, some newly diagnosed patients experience a temporary “honeymoon period,” during which the pancreas still produces some residual insulin, allowing for reduced or even paused insulin therapy for a period of weeks or months. This phase does not last indefinitely — over time, remaining beta cell function typically declines, and insulin therapy needs to resume or increase.
Ongoing research — including efforts to convert immature or stem-cell-derived cells into functioning, insulin-producing beta cells, alongside immunotherapy approaches aimed at reducing the immune attack on the pancreas — represents the frontier of investigational treatment in this space. Reported improvements associated with stem cell–based approaches include better glucose stability, reduced hypoglycemic episodes, and in some cases reduced insulin dependence, though individual results vary considerably. See our page on Diabetes Treatment Results for combined outcome data across Type 1 and Type 2 patients.
Testimonials
Arjun P. – Delhi, India – January 2020 – ⭐⭐⭐⭐☆
“I lived on daily insulin injections. After Viezec’s stem cell therapy, my sugar levels stabilized, and I need much less insulin now.”
Emily R. – Manchester, UK – June 2020 – ⭐⭐⭐⭐⭐
“Managing Type 1 diabetes was exhausting. Post-treatment at Viezec, my blood sugar improved, and I feel energetic again.”
Omar K. – Cairo, Egypt – November 2020 – ⭐⭐⭐⭐☆
“I had poor sugar control despite strict diet. Stem cell therapy at Viezec lowered my HbA1c, and I feel healthier and more active.”
Isabella V. – Rome, Italy – March 2021 – ⭐⭐⭐⭐⭐
“I was dependent on multiple insulin shots daily. After Viezec’s therapy, my requirements dropped, and my stamina improved.”
George N. – Athens, Greece – August 2021 – ⭐⭐⭐⭐☆
“Type 1 diabetes made me constantly tired. Viezec’s stem cell treatment improved my glucose stability and gave me new hope.”
Hannah S. – Toronto, Canada – February 2022 – ⭐⭐⭐⭐⭐
“For years, I lived with uncontrolled sugars. After treatment at Viezec, my readings stabilized, and I feel more confident.”
Mohammed A. – Dubai, UAE – September 2022 – ⭐⭐⭐⭐☆
“My son had Type 1 diabetes since childhood. Stem cell therapy at Viezec improved his glucose levels and reduced his insulin need.”
Maria C. – Madrid, Spain – April 2023 – ⭐⭐⭐⭐⭐
“Daily fatigue from diabetes was draining. After Viezec’s therapy, I have more energy, and my sugar levels are under control.”
Daniel K. – Sydney, Australia – October 2023 – ⭐⭐⭐⭐☆
“I was worried about long-term diabetes complications. After stem cell treatment at Viezec, my sugar control improved drastically.”
Fatima L. – Istanbul, Turkey – May 2025 – ⭐⭐⭐⭐⭐
“Type 1 diabetes had taken away my peace of mind. Viezec’s stem cell therapy reduced my insulin use, and I feel healthier overall.”
Treatment Results
Diabetes management remains a significant global health challenge, and Type 1 diabetes in particular requires precise, lifelong insulin management with frequent glucose monitoring. Researchers are exploring whether stem cell–based approaches may offer a complementary path — specifically by supporting the formation of new islet cells within the pancreas and encouraging existing insulin-producing cells to function more effectively.
While current evidence does not point to a complete cure, some patients undergoing this investigational therapy have reported extended periods with reduced reliance on insulin injections, alongside improvements in overall glucose stability. For broader combined outcome data spanning both Type 1 and Type 2 patients, see the Treatment Results section on our main Diabetes page, or watch patient outcome videos on our YouTube channel.
Our Promise
At Viezec, our goal is to give every Type 1 diabetes patient access to the most current, evidence-informed regenerative treatments available, delivered by qualified and experienced specialists. We hold our procedures to strict international patient-safety standards and aim to create an environment of compassion and trust — treating every visiting patient the way we would a close friend or family member. Flexible payment and support options are also available to help patients focus on their treatment rather than logistics.
Learn more about why international patients choose India for regenerative care on our Why Stem Cell Therapy in India page.
Certificate of Analysis for Type 1 Diabetes Patient
With the Viezec team, every patient gets a certified and authentication quantity of stem cells for treatment. Then, before the transplantation procedure, a few portions of blood, bone marrow, and other microorganisms that need treatment are sent to a certified research facility to separate and improve the cells.
Click here to learn more about the therapy.
Type 1 Diabetes Happy Patient Video’s
Hussain from Saudi Arabia Came to India for Stem Cell Treatment for Diabetes Type 1..Watch Video
Father of Kumari Kritika Saini -MP-stem cell therapy for Diabetes Mellitus type1 treatment..Watch Video
Stem Cell Therapy for Diabetes Type 1 – Mr Hussain Saudi Arabia..Watch Video
Mrs Dan Devi I Diabetes Treated Through Stem Cell Therapy..Watch Video
Before undergoing this procedure, patients should understand that stem cell therapy remains an experimental, investigational approach and may not produce the desired outcome in every case. Depending on individual evaluation, treatment may be declined, or the recommended protocol may be adjusted based on the patient’s health status at the time of assessment.
Our priority is to offer the safest, most current techniques available, aligned with internationally recognized standards. As with any medical treatment, no outcome can be guaranteed — individual biology varies, and results differ between patients even with similar diagnoses. No fetal or embryonic stem cells are used in any of our treatment protocols.
Scientific References
The following peer-reviewed publications and clinical studies support current research on stem cell therapy for Type 1 Diabetes.
Conclusion
Stem cell therapy for Type 1 Diabetes is redefining the possibilities of long-term glucose control and pancreatic cell regeneration. At Viezec, we combine advanced regenerative medicine techniques with patient-focused care to help individuals achieve better insulin independence and improved quality of life. Our ethical medical practices, collaboration with accredited hospitals, and adherence to international standards ensure the highest level of safety and transparency. With India becoming a leading destination for innovative stem cell treatments, Viezec offers patients around the world a reliable path toward sustainable health improvement. To learn more or explore personalized therapy options, connect with our experienced medical consultants today.
Ethical & Transparent Patient Guidance
We provide consultation, case evaluation, and patient support services in regenerative medicine.
As per Indian guidelines, stem cell-based interventions (beyond approved uses) are
investigational and available only within regulated clinical research settings.
We also assist patients in accessing internationally accredited treatment pathways.
Other Disease Treatment
Our Testimonials
Related Videos
Recent Blog Posts
4.8 average based on 654 reviews.
